10 Tips to Combat Coronavirus 10 Tips to Combat Coronavirus


Meet the Sacklers: The Family That's Killing Millions (Maybe More Than Stalin)

opioid addiction

Story at-a-glance -

  • Opioids are now the leading cause of death among Americans under the age of 50. Between 2002 and 2015, more than 202,600 Americans died from overdosing on opioids
  • The massive increase in opioid sales has been blamed on an orchestrated marketing plan aimed at misinforming doctors about the addictive potential of these drugs
  • Purdue Pharma was one of the most successful in this regard, driving sales of OxyContin up from $48 million in 1996 to $1.5 billion in 2002
  • Purdue Pharma is owned by the Sackler family, whose estimated worth is about $14 billion. While well-known for their philanthropic pursuits, the Sacklers have been careful not to associate the family name with Purdue Pharma or OxyContin
  • In 2007, Purdue Pharma pleaded guilty to charges of misbranding OxyContin “with intent to defraud and mislead the public,” and paid $634 million in fines. A non-prosecution agreement accompanying the settlement shielded the Sackler family members from personal accountability

By Dr. Mercola

The U.S. has a massive opioid addiction problem. According to the U.S. surgeon general, more Americans now use prescription opioids than smoke cigarettes, and addiction to narcotic pain relievers now costs the U.S. more than $193 billion each year. The Manchester, New Hampshire, fire department recently said it now responds to more calls for drug overdoses than fires. That's not so surprising when you consider that opioids are now the leading cause of death among Americans under the age of 50.

Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access